|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 27/00 | (2006.01) |
| (11) | Number of the document | 3448848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17718560.0 |
| Date of filing the European patent application | 2017-04-25 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-27 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/EP2017/059767 |
| Date | 2017-04-25 |
| (87) | Number | WO 2017/186703 |
| Date | 2017-11-02 |
| (30) | Number | Date | Country code |
| 16167652 | 2016-04-29 | EP |
| (72) |
THALER, Tobias , DE
PLATZEK, Johannes , DE
GUIMOND, Nicolas , DE
|
| (73) |
Bayer Pharma Aktiengesellschaft ,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Polimorfinė N-{6-(2-hidroksipropan-2-il)-2-[2-(metilsulfonil)etil]-2H-indazol-5-il}-6-(trifluormetil)piridin-2-karboksamido forma |
| POLYMORPHIC FORM OF N-{6-(2-HYDROXYPROPAN-2-YL)-2-[2-(METHYLSULPHONYL)ETHYL]-2H-INDAZOL-5-YL}-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-04-08 | 8 | 185.00 EUR |
| 2025-04-25 |